Page results
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
RAID (Rapid Access Infectious Diseases) clinic is an outpatient service located at the Hospital for Tropical Diseases (address and directions overleaf).
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
We run two separate Urogynaecology services at UCH: The Urogynaecology and Pelvic Floor Unit and The Female Pelvic Medicine and Reconstructive Surgery Unit.
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
This patient information has been written for patients who are being given post exposure prophylaxis.
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Information for UCLH patients requiring complex congenital gynaecology or with differences of sex development.
File results
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease
-
FOI/2022/0451 - Patient information leaflets
-
FOI/2022/0454 - Temporary staff waiting list initiative and overtime spend
-
FOI/2022/0456 - Treatment of renal cell carcinoma
-
FOI/2022/0459 - Interpreters and translation services
-
FOI/2022/0465 - Treatment of dermatological conditions